Human Genomics and Preventive Health Care

The Human Genomics Programme at FIMM builds on a long Finnish tradition of high-impact genetic research. Right now, the rapidly increasing capacity to describe the complete genetic and molecular makeup of an individual is changing the way we understand and treat disease. We foresee that Finland has a unique opportunity to be at the forefront of this developing field. To meet this upcoming grand challenge and opening, our strategy is to work towards building a platform that integrates genomic and health outcome data from Finnish national population biobanks into a globally unique and valuable “big data” repository.

The disease areas of interest for the research groups cover cardiovascular disease, diabetes, immunological diseases, neurology, and neuropsychiatric diseases.

You can learn more about the Principal Investigators and their research groups and projects in Human Genomics by clicking the turning boxes below. In addition, several FIMM Senior Researchers have their own research projects.  


Last updated: 05.11.2018 - 15:16